Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.
暂无分享，去创建一个
J. Blay | O. Mir | A. Italiano | S. Piperno-Neumann | E. Kalbacher | N. Penel | N. Isambert | F. Duffaud | S. Chabaud | C. Bouvier | C. Chevreau | V. Vidal | P. Boudou-Rouquette | O. Collard | E. Saâda | C. Delcambre | J. Delaye | C. Schiffler | E. Bompas